Company Name:Clovis Oncology Inc.
CEO: Patrick J. Mahaffy

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.


Key numbers

Market Capitalization:715040065
Shares Outstanding: 72592900
Float: 69303425
Next Earning Date:2020-02-25
TTm EPS: -7.5072
TTm Dividend Rate:
200 days moving average:10.81
50 days moving average: 9.79
One day percent Change: -7.21



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,